PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹156 Cr | ₹176 Cr | ₹437 Cr | ₹548 Cr | ₹467 Cr |
What is the latest Contingent Liabilities ratio of PFIZER ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹156 Cr |
| Mar2024 | ₹176 Cr |
| Mar2023 | ₹437 Cr |
| Mar2022 | ₹548 Cr |
| Mar2021 | ₹467 Cr |
How is Contingent Liabilities of PFIZER Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹156 Cr | -11.64 | |
| Mar2024 | ₹176 Cr | -59.62 | |
| Mar2023 | ₹437 Cr | -20.37 | |
| Mar2022 | ₹548 Cr | 17.47 | |
| Mar2021 | ₹467 Cr | - | |
Compare Contingent Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹22,263.9 Cr | 0.1% | -3.1% | -10.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 0.1% |
-3.1% |
-10.7% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses